Sign In

Benjamin Oakes

Co-Founder - CEO at Scribe Therapeutics

Benjamin L. Oakes, Ph.D., is the co-founder, President, and Chief Executive Officer of Scribe Therapeutics, a molecular engineering company focused on developing CRISPR-based therapies to treat the underlying causes of diseases.14 He received his Ph.D. in Molecular and Cellular Biology from UC Berkeley in 2017, where he worked in the Doudna Lab and Savage Lab, developing CRISPR-Cas9 molecules with enhanced characteristics.12

Dr. Oakes has made significant contributions to the field of genetic engineering, with over 25 publications and patent applications in areas such as synthetic biology, molecular engineering, and CRISPR and zinc finger-based genetic modification.13 His work has earned him recognition in the biotech industry, including being named to Endpoints 20 Under 40 in biopharma and Business Insider 30 Under 40 transforming healthcare.1

Prior to founding Scribe Therapeutics, Oakes was an Innovative Genomics Institute Entrepreneurial Fellow, where he focused on the holistic engineering of genome editing technologies.14 He co-founded Scribe in 2018 along with Nobel Laureate Jennifer Doudna, David Savage, and Brett Staahl.27

Under Oakes' leadership, Scribe Therapeutics has developed a platform called CRISPR by Design™, which aims to create custom CRISPR molecules specifically for therapeutic use within the human body.17 The company has secured significant funding and partnerships, including collaborations with major pharmaceutical companies like Sanofi and Biogen.57

Dr. Oakes' vision for Scribe Therapeutics is to revolutionize the development of in vivo CRISPR-based genetic medicines, with a focus on treating highly prevalent diseases, starting with cardiometabolic conditions.6

Highlights

Feb 23 · youtube.com
The Age of CRISPR: Engineering the Future of Genetic Medicine
The Age of CRISPR: Engineering the Future of Genetic Medicine
Feb 20 · a16z.com
CRISPR by Design with Benjamin Oakes - Andreessen Horowitz
Jul 25 · forbes.com
This Scientist Is Building Custom Gene-Editing Tools—And Stands ...
Oct 22 · biocom.org
Benjamin Oakes, Ph.D. - Biocom California
Benjamin Oakes, Ph.D. - Biocom California

Related Questions

What are some of the key achievements of Benjamin Oakes at Scribe Therapeutics?
How did Benjamin Oakes' work in the Doudna Lab influence his career?
What are the main goals of Scribe Therapeutics under Benjamin Oakes' leadership?
How has Benjamin Oakes contributed to the field of CRISPR technology?
What awards and recognitions has Benjamin Oakes received in his career?
Benjamin Oakes
Benjamin Oakes, photo 1
Benjamin Oakes, photo 2
Add to my network

Location

Berkeley, California